A Genomics Revolution: Personalized Medicine

Genetics & adverse drug reactions, screening for treatable diseases in the genomic age, and is personalized medicine worth the cost? Presented by Dr. Colin Ross, Scientist, Department of Medical Genetics, UBC. | Dr. Clara van Karnebeek, Clinical Fellow, Biochemical Genetics, BC Children's Hospital. | Dr. Carlo Marra, Associate Professor, Faculty of Pharmaceutical Sciences, UBC; Research Scientist, Centre for Health Evaluation & Outcome Sciences, Providence Health Care; Canada Research Chair, Pharmaceutical Outcomes. (2010)

Researchers Colin Ross, Clara van Karnebeek

Research Areas

Genetic Testing

Genetic Research

Recent News See all

BCCHR research could help set new international standard for young children receiving bone marrow transplants

The findings from a BCCHR study played a part in integrating the multiple breath washout test into recent recommendations to screen children for pulmonary chronic graft-versus-host disease, a lung complication that can affect children who undergo a bone marrow transplant.

Continue reading BCCHR research could help set new international standard for young children receiving bone marrow transplants

Beyond access: Moving towards equity in pediatric type 1 diabetes care

Managing type 1 diabetes (T1D) can be challenging for patients, especially those from marginalized populations facing structural inequities. Families affected by T1D often grapple with managing a complex condition that requires continuous monitoring, timely insulin administration, and strict adherence to treatment plans. These challenges can be exacerbated for patients in socioeconomically deprived communities, where access to care and diabetes technology is often limited.

Continue reading Beyond access: Moving towards equity in pediatric type 1 diabetes care

New study makes key findings in potential advancement of diabetes cure

New research published in Nature Communications, identifies a key molecule that might be critical for the development of stem cell-based therapies for treating type 1 diabetes.

Continue reading New study makes key findings in potential advancement of diabetes cure

Pneumonia and malaria: Innovations tackle leading threats to children under five

Globally, pneumonia and malaria are among the leading causes of death for children under five, due in part to health-care resource gaps in low- and middle-income countries. New BCCHR investigator and pediatric infectious diseases expert Dr. Michael T. Hawkes is developing diagnostic and treatment tools to address these shortages.

Continue reading Pneumonia and malaria: Innovations tackle leading threats to children under five

Dr. Kirk Schultz awarded the 2024 Geoffrey L. Hammond Lectureship

Dr. Kirk Schultz, an investigator at BC Children’s Hospital Research Institute, has been awarded the 2024 Geoffrey L. Hammond Lectureship in recognition of his leadership and significant contributions to improving the health and well-being of children in British Columbia and around the world.

Continue reading Dr. Kirk Schultz awarded the 2024 Geoffrey L. Hammond Lectureship

Donate to Research

We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.

Give Now

A Genomics Revolution: Personalized Medicine

A Genomics Revolution: Personalized Medicine

Recent News See all

BCCHR research could help set new international standard for young children receiving bone marrow transplants

Beyond access: Moving towards equity in pediatric type 1 diabetes care

New study makes key findings in potential advancement of diabetes cure

Pneumonia and malaria: Innovations tackle leading threats to children under five

Dr. Kirk Schultz awarded the 2024 Geoffrey L. Hammond Lectureship

Donate to Research

Stay in the know